Patients with liver disease exhibit an almost complete lack of biliary and plasma deoxycholic acid,'-3 raised plasma bile acids,45 a decrease in cholic acid pool size," and a diminution in the hepatic clearance of labelled bile acids.89 Biliary cholesterol secretion is reduced more than the secretion of bile acids and phospholipids,'°and micellar solubilisation of intestinal lipids and sterols can be markedly reduced. " Faecal bile acids and neutral sterols of cholesterol origin are decreased in patients with severe chronic liver disease, while urinary bile acids are constantly, but never greatly, increased,'2 indicating that the production of cholesterol and its conversion to bile acids is decreased.
The abnormalities of biliary lipids in liver diseases have been mainly reported in alcoholic cirrhosis and factors affecting different aspects of sterol metabolism are poorly understood. In the present study the biliary lipids, faecal steroids, and serum bile acids were Received for publication 21 January 1981 studied in patients with chronic active hepatitis and primary biliary cirrhosis. The results have been correlated with each other, routine liver function tests and histochemical orcein-staining of liver biopsies.
Orcein-positive copper-protein complexes'3 have been found in severe chronic cholestatic states.'4"' Some preliminary results of the investigation have been presented earlier. '6 Methods
PATIENTS
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chronic active hepatitis and clearly raised in primary biliary cirrhosis (Table 2) , even though several cases with the latter disorder had no hypercholesterolaemia. In general, the serum cholesterol level was higher in the orcein-positive than orcein-negative subjects. Serum triglycerides were not consistently affected in either chronic active hepatitis or primary biliary cirrhosis. Serum fasting bile acids were similar in both disorders, but they were higher in the orcein-positive than orcein-negative patients in both primary biliary cirrhosis and chronic active hepatitis.
BILIARY LIPID COMPOSITION
Biliary lipid composition was normal in the patients with CAH and PBC (Table 3) . However, the molar percentage of cholesterol was low and that of bile acids high in the orcein-positive patients. When the molar percentages of the whole material were plotted the respective correlation between the two dihydroxy bile acids being less significant (r= -0-33; P<0-05; n=51). The percentage of biliary cholic acid was positively associated with serum alkaline phosphatase, leucine aminopeptidase, gamma-glutamyl transpeptidase, bilirubin, cholesterol, and fasting bile acids and negatively with serum albumin and the transport maximum of bromosulphophthalein. On the other hand, the dihydroxy bile acids, deoxycholate in particular, correlated negatively with those tests.
FAECAL FAT AND STEROIDS
An increased faecal fat (7 g/day) was found in four orcein-positive patients only, one with chronic active hepatitis and three with primary biliary cirrhosis. However, the mean faecal fat was higher in the orcein-positive patients, in the cirrhosis patients in particular, than in orcein-negative patients or controls ( Table 2 ). The mean faecal bile acid output was lower in patients with these disorders and, especially in the orcein-positive patients, than in the controls. Faecal bile acids were not associated with faecal fat or the liver function tests but they correlated positively with the percentage of biliary deoxycholate ( Figure) , and negatively with the percentage of biliary cholic acid (r=-0 52; P<0O001; n=50), with serum bile acids (r=-0-39; P<0-05; n=32), and with serum cholesterol (r= -0-35; P<0.05; n=32).
In contrast with bile acids, the faecal excretion of neutral and total sterols was similar in all the patient groups and the controls. However, if abnormal alkaline phosphatase and P+P (prothrombin+ proconvertin) were used to separate subgroups according to excretory and parenchymal liver function (Table 5 ) the patients with impairment of both excretory and parenchymal function had decreased faecal neutral and acidic steroids indicative of low bile acid and cholesterol synthesis. In primary biliary cirrhosis the total steroid values (faecal bile acids+ neutral steroids of cholesterol origin) were not correlated with any of the liver function tests or serum cholesterol. In orcein-negative chronic active hepatitis patients the total steroid output was negatively correlated with serum cholesterol (r=-050; P<0.05; n=17) and alkaline phosphatase (r=-0.61; P<001; n=18), but not with the parenchymal liver function tests. Serum cholesterol 5 4±0(5 5.5±0Q.3f 87±1 2* 5.9±0.4t Serum bile acids 019±0(4 0.7±0(1 6 8±2.8 4-1±2-7 Biliarv cholic acid () 382±22254 0±28* 57.8+3 1* 53.6-5.9* Biliarv deoxycholic acid () 22 8±45 98±35 6 1 + 1 9* 6.7±2-6* Biliarv chenodeoxvcholic acid (%)39 0±3 0 36.2±2.0 361+-2-6 39 7±4-7 Faecal neutral sterols (mg/kg/day) 108±1.3 12.8-3.0 9 4±0)9 7.8±0(6 Faecal bile acids (mg/kg/dav) 5 1±0 6 3.4±0(6 3-1+0-4 * 2+205S Total faecal steroids (mg/kg/day) 15 9±1 3 16.3±3 0 12.6± 11 10 0±0 9* Impairment in excretory liver function was evaluated by serum alkaline phosphatase (AFOS) and that of parenchymal liver function by plasma prothrombin (P+P). AFOS-: <244 U/I. AFOS+=>244 U/I. P+P-=>75. p+p=+ =75 *Statisticaliv significant difference (p<0(05 or less) from group A. tStatisticaliv significant difference (p<005 or less) from group C.
Discussion
Analysis of biliary lipid composition has revealed that in patients with severe alcoholic liver cirrhosis the cholesterol saturation is subnormal.' This is associated with a decrease in the secretion rates of all the three biliary lipids, cholesterol, bile acids, and phospholipids.40 In less severe forms of alcoholic cirrhosis, however, these disturbances in biliary lipid metabolism have not been found.4' In the present study the mean biliary lipid composition of the patients with chronic active hepatitis and primary biliary cirrhosis was within the control limits, despite clear-cut abnormalities in the liver functions tests. However, the severity of the diseases varied markedly and the tests of the secretory function were affected more consistently than those of the parenchymal cell function (Table 1) , not only in primary biliary cirrhosis but in chronic active hepatitis, too. Further subgrouping according to the presence of orceinpositive material in the liver biopsies separated from both groups of disorder the patients whose secretory liver function tests were most abnormal. This subgrouping, however, separated inconsistently the patients with poor parenchymal cell function. Even though the molar percentage of biliary lipids was not correlated with the liver function tests the finding on the association of the low molar percentage of biliary cholesterol with the orcein positivity indicates that in chronic active hepatitis and primary biliary cirrhosis the bile does not become undersaturated for cholesterol until in the advanced stage of impaired secretory dysfunction.
A decrease in the relative amount of biliary deoxycholic acid and an increase in that of cholic acid characterise the bile acid pattern of cholestatic liver diseases. 1-3 Impaired parenchymal cell function reduces bile acid synthesis, especially that of cholic acid, resulting in a relative increase in chenodeoxycholic acid.67 These observations are confirmed in the present study for both primary biliary cirrhosis and chronic active hepatitis, for orcein-positive subjects in particular. The inconsistent change in biliary chenodeoxycholic acid indicates, however, that the parenchymal cell function was relatively well preserved. This is in accordance with the recent finding that the synthesis and pool size of chenodeoxycholic acid remain unabated in the patients with primary biliary cirrhosis.42 A negative correlation between the percentages of cholic and chenodeoxycholic acid could be a sign of impaired parenchymal function, though the tests of the parenchymal cell function correlated poorly with the percentage distributions of biliary bile acids. In contrast, the surprisingly strong correlation of the biliary bile acid percentage distribution with the serum bile acid and cholesterol levels and with other tests of cholestasis suggests that the changes in biliary bile acids are related to cholestasis.
Absence of steatorrhoea in the present series does not necessarily mean that the biliary secretion of bile acids was sufficient to maintain the intestinal bile acid level above the critical micellar concentration during fat digestion. Fatty acids are absorbed along the small intestine to some extent without micellar solubilisation.434 Thus, in patients with liver disease and severe disturbance of micellar formation, faecal fat can be modestly increased only. 2 In fact, low biliary bile acid secretion associated with normal bile acid absorption could explain low faecal bile acids in the present series. The low faecal bile acid output and the low biliary cholesterol saturation, in orcein-positive subjects in particular, actually suggest that the secretion of biliary lipids had decreased and that the output of biliary cholesterol had decreased even more than that of bile acids. Two possible mechanisms can then be visualised for normal faecal neutral sterols in the present series. First, reduced biliary bile acid secretion impaired micellar solubilisation of lipids. In contrast with fatty acids, micellar solubilisation is a prerequisite for cholesterol absorption.4546 Thus, bile acid deficiency reduced absorption of both dietary and endogenous cholesterol, particularly in the orcein-positive subjects, so that faecal output of neutral sterols remained normal. Secondly, cholesterol secretion via the intestinal mucosa may be increased. This is possible because mucosal cholesterol synthesis is high in bile acid deficiency.47 Furthermore, reabsorption of mucosal cholesterol may also be markedly reduced. At the moment, the magnitude of mucosal cholesterol secretion, cholesterol malabsorption, and impaired biliary lipid secretion is not at all, or only partially, known in patients with chronic active hepatitis and primary biliary cirrhosis. In conclusion, the present findings indicate that mild disturbances in parenchymal liver function cause infrequently major changes in cholesterol metabolism. However, abnormalities in secretory liver function are often associated with changes in cholesterol metabolism, especially in patients with orcein-positive hepatocellular deposits. 
